BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Myriad Genetics, Inc. 

320 Wakara Way

Salt Lake City  Utah  84108  U.S.A.
Phone: 801-584-3600 Fax: 801-584-3640


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Myriad Genetics, Inc. (MYGN) Names Bernard Tobin As President Of Crescendo Bioscience 12/22/2014 7:44:13 AM
Myriad Genetics, Inc. (MYGN) Snags FDA Approval of BRACAnalysis CDx as Companion Diagnostic for Lynparza 12/22/2014 6:28:23 AM
Myriad Genetics, Inc. (MYGN) Receives FDA Approval Of BRACAnalysis CDx™ As Companion Diagnostic For Lynparza™ (olaparib) In Ovarian Cancer Patients 12/19/2014 11:12:26 AM
Ambry Genetics Defeats Appeal By Myriad Genetics, Inc. (MYGN) To Restrict Market For Breast-Ovarian Cancer Genetic Testing 12/18/2014 10:33:17 AM
Three New Myriad Genetics, Inc. (MYGN) Studies Highlighted At 2014 San Antonio Breast Cancer Symposium 12/9/2014 1:07:58 PM
Myriad Genetics, Inc. (MYGN) To Present Eight Studies At 2014 San Antonio Breast Cancer Symposium 12/3/2014 1:04:53 PM
Myriad Genetics, Inc. (MYGN) Release: Study Shows Prolaris Could Save Healthcare System $6 Billion Over 10 Years 12/2/2014 3:11:05 PM
Tesaro, Inc. (TSRO) And Myriad Genetics, Inc. (MYGN) Announce Companion Diagnostics Collaboration 11/20/2014 10:44:14 AM
Myriad Genetics, Inc. (MYGN) myPath™ Melanoma Improves Diagnosis And Treatment Plans 11/7/2014 11:58:49 AM
Myriad Genetics, Inc. (MYGN) Reports Fiscal First Quarter 2015 Financial Results 11/5/2014 7:30:30 AM
12345678910...